Artiva Biotherapeutics, Inc. (ARTV)
6.69
-0.14
(-2.05%)
USD |
NASDAQ |
Oct 05, 10:50
Artiva Biotherapeutics Net Income (Quarterly) : -25.00M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.00M |
| March 31, 2026 | -23.52M |
| December 31, 2025 | -20.77M |
| September 30, 2025 | -21.53M |
| June 30, 2025 | -21.25M |
| March 31, 2025 | -20.31M |
| December 31, 2024 | -16.10M |
| September 30, 2024 | -17.47M |
| June 30, 2024 | -17.84M |
| Date | Value |
|---|---|
| March 31, 2024 | -13.96M |
| December 31, 2023 | -12.00M |
| September 30, 2023 | 11.28M |
| March 31, 2023 | -16.72M |
| March 31, 2022 | -12.12M |
| December 31, 2021 | -11.39M |
| March 31, 2021 | -42.72M |
| December 31, 2020 | 0.00 |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Climb Bio, Inc. | -13.50M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.00M |
| EPS Diluted (Quarterly) | -0.6344 |
| Enterprise Value | -6.294M |
| Earnings Yield | -49.51% |
| Normalized Earnings Yield | -49.51 |